Twinrix vaccine syringeml

Ended Awarded Last action

Contract number
SPE2D326F5836
Awardee
Awarding agency
Obligated
$10,848

Award facts

Contract value 100% obligated
$10,848.37 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $10,848.37 for Twinrix vaccine in syringe form. DMS Pharmaceutical Group Inc. is a woman-owned small business.

This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The order has an ultimate completion date of February 10, 2026. Pricing is firm fixed price.

Quick answers

Who was awarded contract SPE2D326F5836?

SPE2D326F5836 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on February 9, 2026.

How much is contract SPE2D326F5836 worth?

The government has obligated $10,848 on SPE2D326F5836.

Is contract SPE2D326F5836 an order under another contract?

Yes. SPE2D326F5836 is a delivery order under SPE2D021DA002, an indefinite delivery contract.

Was contract SPE2D326F5836 competed?

The extent of competition for SPE2D326F5836 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award